Newly Released OpenClinica 3.1 Will be Demonstrated at the Drug Information Association Annual Meeting
OpenClinica, LLC is pleased to announce the production release of OpenClinica 3.1, the culmination of 18 months of effort for the growing open source electronic data capture software company. OpenClinica enhances the productivity of clinical trials through highly capable, flexible, commercial open source software. The software is freely available for download at https://community.openclinica.com.
“OpenClinica 3.1 is the most capable, easy to use, and flexible release to date,” said Cal Collins, OpenClinica’s CEO. “The software improves the efficiency of data managers, monitors, and site users to capture and clean data, provides a way to easily customize data extract formats, includes an expanded web services interface to facilitate interoperability with other systems and data sources, and supports dynamic skip logic in case report forms. Both the Enterprise and Community editions of the software have been heavily tested at OpenClinica and by beta users in the open source community over the past six months, and we are pleased to release the technology for general production use.”
OpenClinica will hold demonstrations of the new software and answer questions at the Drug Information Association’s 47th Annual Meeting this month in Chicago (booth #1843), which kicks-off on June 19th.
Sound technology and a model that makes it easy to both adopt and adapt has propelled the growth of OpenClinica. Earlier this month, the company released statistics showing that over the last year, the number of clinical trials powered by OpenClinica grew by 250 percent. Collins says there are over 400 active production implementations worldwide and a single implementation can support multiple trials.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
